Phase 1 Study Of Ziprasidone Pharmacokinetics Of Reduced Food Effect Formulation B16 Under Fed And Fasting Conditions Compared To Commercial Geodon Capsules Under Fed Conditions In Healthy Subjects.

Trial Profile

Phase 1 Study Of Ziprasidone Pharmacokinetics Of Reduced Food Effect Formulation B16 Under Fed And Fasting Conditions Compared To Commercial Geodon Capsules Under Fed Conditions In Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Apr 2011

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Anxiety disorders
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 19 Mar 2009 Actual patient number (11) added as reported by ClinicalTrials.gov.
    • 19 Mar 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
    • 19 Mar 2009 Actual initiation date changed from Feb 2009 to Jan 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top